tradmap

ARWR Arrowhead Pharmaceuticals, Inc.

$86.53 +1.34%

Updated

Healthcare · Pharmaceutical Preparations

Arrowhead Pharmaceuticals, Inc. (ARWR) is a healthcare company in the Pharmaceutical Preparations industry, with a market capitalization of $12.2 billion. Shares last traded at $86.53, 9.3% below their 52-week high. Over the past year the stock is up 211.1%. Net profit margin is -47.8%, below the peer median of -8.9%. Revenue grew 23258.2% year over year.

Market Cap
$12.2B
Shares Out
141.3M
EPS (TTM)
$-2.44
P/E Ratio
P/S Ratio
18.26
P/B Ratio
26.26
Dividend / Share
Dividend Yield
52-Week High
$95.41
52-Week Low
$27.10
Volume
75,978
Avg Vol (3m)
96,689.81

Performance

1W
-2.32%
1M
-0.37%
3M
+15.12%
6M
+36.10%
YTD
+27.68%
1Y
+211.15%

Daily candles · volume · SMA(20)/SMA(50) · Databento EQUS.MINI.

Technicals

RSI (14)
51.99
SMA (50)
$83.88
SMA (200)
$70.90
Price vs SMA50
+3.16%
Price vs SMA200
+22.05%
ATR (14)
$3.47

Full technical analysis (26 indicators, D/W/M) →

Financials

Revenue
$669M
Net Income
$-320M
Gross Margin
Operating Margin
-33.8%
Net Margin
-47.8%
Return on Equity
-68.7%
Return on Assets
-15.1%
Current Ratio
5.90
Debt / Equity
Revenue Growth (YoY)
+23258.2%

Latest reported annual period ending 2026-06-30 · SEC EDGAR/XBRL.

Full financials — revenue, cash flow & debt over time →

Recent earnings

PeriodEPS (diluted)Reported
Q3 2026 $-2.10 2026-08-04
Q2 2026 $-0.73 2026-05-07
Q1 2026 $0.22 2026-02-05
FY 2025 $-0.01 2025-11-25
Q3 2026 $0.17 2026-08-04
Q2 2026 $1.52 2026-05-07

Full earnings history →

Pharmaceutical Preparations peers

ARWR vs 14 industry peers (Pharmaceutical Preparations), by market cap. Updated

P/S vs peers
18.26 / 11.11 med
+64% premium
Net margin vs peers
-47.8% / -8.9% med
below median
1–14 of 14
LLYLilly (Eli)$1.09T40.8613.7033.5%-0.02%
JNJJohnson & Johnson$670.6B31.886.8521.5%+1.04%
ONCBeone Medicines Ltd.$535.9B817.2587.4310.7%+0.23%
ABBVAbbVie$459.8B72.877.149.8%-0.57%
MRKMerck$375.8B118.445.654.8%+0.44%
ABTAbbott Laboratories$189.5B30.204.2013.9%-1.50%
PFEPfizer$164.2B37.912.586.8%-0.76%
VRTXVertex Pharmaceuticals$141.5B32.1111.2435.0%+0.24%
BMYBristol Myers Squibb$139.1B14.982.8318.9%+0.62%
REGNRegeneron Pharmaceuticals$87.2B20.155.6127.9%-1.02%
TEVATeva Pharmaceutical Industries Ltd$42.6B60.412.464.1%-2.32%
ALNYAlnylam Pharmaceuticals$35.4B43.779.5221.8%-1.10%
ZTSZoetis$31.5B12.053.3127.5%+0.16%
RPRXRoyalty Pharma Plc$28.2B34.5611.1132.1%+1.24%

Source: SEC EDGAR (fundamentals/EPS/dividends) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.